| Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection Y Asahina, K Tsuchiya, N Tamaki, I Hirayama, T Tanaka, M Sato, Y Yasui, ... Hepatology 52 (2), 518-527, 2010 | 339 | 2010 |
| Living donor versus deceased donor liver transplantation: a surgeon‐matched comparison of recipient morbidity and outcomes TW Reichman, H Katchman, T Tanaka, PD Greig, ID McGilvray, ... Transplant International 26 (8), 780-787, 2013 | 92 | 2013 |
| Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to … M Kurosaki, T Hosokawa, K Matsunaga, I Hirayama, T Tanaka, M Sato, ... Hepatology Research 40 (9), 870-877, 2010 | 83 | 2010 |
| Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population M Kawashima, Y Hitomi, Y Aiba, N Nishida, K Kojima, Y Kawai, ... Human molecular genetics 26 (3), 650-659, 2017 | 79 | 2017 |
| A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis M Kurosaki, K Matsunaga, I Hirayama, T Tanaka, M Sato, Y Yasui, ... Hepatology research 40 (3), 251-260, 2010 | 72 | 2010 |
| Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma J Shindoh, Y Sugawara, R Nagata, J Kaneko, S Tamura, T Aoki, ... Transplant International 27 (4), 391-398, 2014 | 66 | 2014 |
| A nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan Y Inagaki, Y Oshiro, T Tanaka, T Yoshizumi, H Okajima, K Ishiyama, ... EBioMedicine 2 (11), 1607-1612, 2015 | 63 | 2015 |
| Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response Y Asahina, N Izumi, I Hirayama, T Tanaka, M Sato, Y Yasui, N Komatsu, ... Gastroenterology 134 (5), 1396-1405, 2008 | 48 | 2008 |
| The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy M Kurosaki, K Matsunaga, I Hirayama, T Tanaka, M Sato, N Komatsu, ... Journal of hepatology 48 (5), 736-742, 2008 | 44 | 2008 |
| Liver transplantation and autoimmune hepatitis T Tanaka, Y Sugawara, N Kokudo Intractable & Rare Diseases Research 4 (1), 33-38, 2015 | 37 | 2015 |
| The impact of obesity as determined by modified body mass index on long-term outcome after liver transplantation: Canadian single-center experience T Tanaka, EL Renner, N Selzner, G Therapondos, LB Lilly Transplantation proceedings 45 (6), 2288-2294, 2013 | 37 | 2013 |
| One Year of Hepatitis B Immunoglobulin Plus Tenofovir Therapy is Safe and Effective in Preventing Recurrent Hepatitis B Infection Post‐Liver Transplantation T Tanaka, EL Renner, N Selzner, G Therapondos, LB Lilly Canadian Journal of Gastroenterology and Hepatology 28 (1), 41-44, 2014 | 33 | 2014 |
| Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference JM Pollok, P Tinguely, M Berenguer, CU Niemann, DA Raptis, M Spiro, ... The Lancet Gastroenterology & Hepatology 8 (1), 81-94, 2023 | 30 | 2023 |
| Decision tree analysis to stratify risk of de novo non-melanoma skin cancer following liver transplantation T Tanaka, MD Voigt Journal of cancer research and clinical oncology 144, 607-615, 2018 | 25 | 2018 |
| Living donor liver transplantation for non‐alcoholic steatohepatitis: A single center experience T Tanaka, Y Sugawara, S Tamura, J Kaneko, Y Takazawa, T Aoki, ... Hepatology Research 44 (10), E3-E10, 2014 | 22 | 2014 |
| The long‐term efficacy of nucleos (t) ide analog plus a year of low‐dose HBIG to prevent HBV recurrence post‐liver transplantation T Tanaka, A Benmousa, M Marquez, G Therapondos, EL Renner, LB Lilly Clinical transplantation 26 (5), E561-E569, 2012 | 22 | 2012 |
| Risk factors for acute liver allograft rejection and their influences on treatment outcomes of rescue therapy in living donor liver transplantation J Shindoh, N Akamatsu, T Tanaka, J Kaneko, S Tamura, Y Sakamoto, ... Clinical transplantation 30 (8), 880-885, 2016 | 21 | 2016 |
| Virological response for recurrent hepatitis C improves long‐term survival in liver transplant recipients T Tanaka, N Selzner, G Therapondos, EL Renner, LB Lilly Transplant International 26 (1), 42-49, 2013 | 21 | 2013 |
| The current clinical aspects of idiopathic portal hypertension T Tanaka, Y Sugawara, N Kokudo Intractable & Rare Diseases Research 2 (3), 94-97, 2013 | 19 | 2013 |
| Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization KL Lentine, T Tanaka, H Xiao, T Bittermann, MA Dew, MA Schnitzler, ... Clinical transplantation 37 (7), e14924, 2023 | 16 | 2023 |
